Biogen Idec appoints Spyros Artavanis-Tsakonas chief scientific officer Chris Reidy May 23, 2013 Spyros Artavanis-Tsakonas, HMS professor of cell biology, has been appointed to the post of chief scientific officer of Biogen Idec Inc., the Weston biotechnology company perhaps best known for its multiple sclerosis drugs announced. Read full article
Medical Students Mark Residency Placements at Match Day 2025 March 21, 2025 Soon-to-be doctors thrilled to learn where they will begin clinical training
Are We on the Cusp of a Major Bird Flu Outbreak? March 7, 2025 Scientists weigh in on the spread of H5N1 and highlight clues that portend what might come next
Could Migraine Drugs Help Treat Endometriosis? March 28, 2025 Research in mice suggests headache medications may reduce symptoms of the gynecologic disorder